Cardiac Biomarkers: Technologies and Global Markets

Report Code: BIO128D

Publish Date: Mar 2023

Publisher: BCC Publishing

Category: Cell Biology

Customize This Report

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global market for cardiac biomarkers is estimated to increase from $13.4 billion in 2022 to reach $23.8 billion by 2027, at a compound annual growth rate (CAGR) of 12.2% from 2022 through 2027.

Report Includes

  • 66 data tables and 36 additional tables
  • An up-to-date overview and analysis of the global markets for cardiac biomarkers technologies
  • Analyses of the global market trends, with historic revenue data for 2019-2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
  • Estimation of the actual market size and revenue forecast for cardiac biomarkers market in USD million terms, and corresponding market share analysis based on the type of biomarker, instrument category, and region
  • Identification of the viable technology drivers and barriers through a holistic review of various platform technologies in cardiac biomarker measurement and their notable advancements
  • Complete understanding of the leading cardiac markers and their value in terms of diagnostic testing, screening, prognostic monitoring, pharmacogenomic testing, and theranostics, while also appreciating these elements from their basic principles to their applications
  • Discussion of feasible market opportunities via identification of high-growth applications in different cardiac marker diagnostic testing areas, with a focus on the biggest and fastest-expanding markets for diseases
  • Emphasis on global industry development through an in-depth analysis of the major world markets for cardiac marker diagnostic testing, including forecasts for growth
  • Latest information on the leading companies engaged in research and development (R&D) and products in the cardiac marker diagnostic reagent pipeline with SWOT analyses
  • Review of the patents and patent applications on cardiac biomarkers and deep dive of recent global and region-specific patent publications related to cardiac biomarkers
  • Insight into the company competitive landscape and company value share analysis for the leading suppliers of cardiac biomarkers
  • Profile descriptions of the major global players, including Abbott Laboratories, Beckman Coulter (subsidiary of Danaher Corp.), bioMérieux S.A., PerkinElmer Inc., Roche Diagnostics, Siemens Healthineers, and Thermo Fisher Scientific Inc.

Report Scope

The scope of this report is:

  • Identify viable technology drivers through a comprehensive look at various platform technologies for cardiac marker segments of the diagnostic testing market.
  • Obtain a complete understanding of the leading cardiac markers and their value in terms of diagnostic testing, screening, prognostic monitoring, pharmacogenomic testing and theragnostic, while also gaining an appreciation these elements from their basic principles to their applications.
  • Discover feasible market opportunities via the identification of high-growth applications in different cardiac marker diagnostic testing areas, with a focus on the biggest and fastest-expanding markets for diseases.
  • Focus on global industry development through an in-depth analysis of the major world markets for cardiac marker diagnostic testing, including forecasts for growth.
  • Present market figures for the current value of the cardiac biomarkers market, projections and growth rates. These are developed from the most recently available information from the global diagnostics industry.

By purchasing this study, the reader will gain:

  • An improved understanding of the current state and future of the most exciting cardiac biomarker market segments.
  • The latest information on the leading companies engaged in research and development (R&D) and products in the cardiac marker diagnostic reagent pipeline.
  • Knowledge of the cardiac diagnostic testing market as an area of growth, research and investment.

This analysis covers the following categories of the cardiac biomarker segments:

  • Acute Myocardial Infarction (AMI).
  • Heart failure.
  • Brain natriuretic peptide (BNP).
  • Myoglobin.
  • Homocysteine (Hcy).
  • C-reactive protein (CRP).
  • Pulmonary embolism (PE) D-dimer test.
  • Low-density lipoproteins (LDL) and high-density lipoproteins (HDL).
  • Stroke.
  • Creatine kinase-myocardial band (CK-MB) and cardiac enzymes.
  • Albumin.
  • Cardiac markers are used in clinical decisions.
  • Cardiac markers in renal failure.
  • Troponins in non-ischemic heart disease.
  • Cardiac panels.
  • POC cardiac markers.

Analyses include charts and graphs measuring product growth and trends within the marketplace. In addition, a discussion of research on various illnesses provides the reader with a deeper understanding of the possibilities for future treatment and avenues for possible R&D budgets. Company-specific information, including sales figures, product pipeline status and R&D trends, is provided throughout the report. In addition, the study:

  • Assesses cardiac marker diagnostic testing market drivers and bottlenecks from the perspective of the medical and scientific communities.
  • Discusses the potential benefits of the cardiac marker diagnostic testing market for various sectors of the medical and scientific community.
  • Establishes the current total market size and future growth of the cardiac marker diagnostic testing market and analyzes the current size and growth of individual segments.
  • Provides current and forecasted market shares by company.
  • Discusses profit and business opportunities by diagnostic testing segment.
  • Provides strategic recommendations for near-term business opportunities.
  • Assesses current commercial uses of the cardiac biomarker market.

Report Synopsis

Report Metrics Details
Base year considered 2021
Forecast period considered 2022-2027
Base year market size $11.9 billion
Market size forecast $23.8 billion
Growth rate CAGR of 12.2% for the forecast period of 2022-2027
Units considered $ Millions
Segments covered By Type of Biomarker, Instrument Category, and Region
Regions covered North America, Europe, Asia-Pacific, and Rest of the World (RoW)
Countries covered U.S., Canada, France, Germany, Italy, Spain, U.K., Japan, China, India, South Korea, Australia, Rest of Europe, Rest of APAC
Key Market Drivers
  • Rising Prevalence of Cardiovascular Diseases (CVD)
  • Technological Advancements in Cardiac Biomarkers
  • Increased Funding from Public-Private Organizations for Research on Cardiac Biomarkers
  • Rising Demand for Point-of-Care (POC) Cardiac Testing Kits
  • High Specificity in the Detection of Cardiac Diseases
Companies studied
ABBOTTACS BIOMARKER BV
BECKMAN COULTER INC. (SUBSIDIARY OF DANAHER CORP.)BG MEDICINE INC.
BIOMERIEUXBIO-RAD LABORATORIES INC.
CARDIOGENICS INC.CREATIVE DIAGNOSTICS
CRITICAL DIAGNOSTICSLIFE DIAGNOSTICS
LIFESIGN LLCLSI MEDIENCE CORP.
MERIDIAN LIFE SCIENCE INC.METANOMICS HEALTH GMBH
ORTHO-CLINICAL DIAGNOSTICSPERKINELMER
PTS DIAGNOSTICSQUIDELORTHO CORP.
RADIOMETER MEDICAL APSRANDOX LABORATORIES LTD.
RESPONSE BIOMEDICAL CORP.F. HOFFMANN-LA ROCHE LTD.
SANYO CHEMICAL INDUSTRIES LTD.SIEMENS
SINGULEX INC.SPECTRAL MEDICAL INC.
THERMO FISHER SCIENTIFIC INC.TOSOH BIOSCIENCE INC.
TRINITY BIOTECH PLC
Need pricing for multiple titles, a complete report bundle, or something specially curated to fit your budget? EXPLORE OFFERS

Frequently Asked Questions (FAQs)

The cardiac biomarkers market is projected to grow from $11.9 billion in 2021 to $23.8 billion in 2027, at a compound annual growth rate (CAGR) of 12.2% during the forecast period.
The key factors driving the growth of cardiac biomarkers market includes rising prevalence of cardiovascular diseases, technological advancements in cardiac biomarkers, rising demand for point-of-care (POC) cardiac testing kits, and high specificity in the detection of cardiac diseases.
The cardiac biomarkers market is segmented based on biomarker type, by instrument category, and region.
Troponin segment will dominate the market by the end of 2027.
North America holds the highest share in the market.
Key companies in the market includes Roche Laboratories, Abbott Laboratories, Siemens AG, Thermo Fisher Scientific, Beckman Coulter (Part of Danaher), Bio-Rad Laboratories, BioMérieux, Tosoh Bioscience, Ortho-Clinical Diagnostics, Quidel Corp., CardioGenics, Meridian Life Science, Sanyo Chemical Industries Ltd., Spectral Medical Inc., Trinity Biotech, and other key players.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Latest reports include:
Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Cardiac Biomarkers: Technologies and Global Markets287Free
Chapter- 1: Introduction10Free
Chapter- 2: Summary and Highlights4Free
Chapter- 3: Cardiovascular Disease and Its Associated Burden31Free
Chapter- 4: Introduction to Cardiac Biomarkers35Free
Chapter- 5: Review of Key Individual Cardiac Biomarkers42Free
Chapter- 6: Global Market for Cardiac Biomarkers41Free
Chapter- 7: Impact of the COVID-19 Pandemic3Free
Chapter- 8: Regulatory and Legislative Requirements for Cardiac Biomarkers51Free
Chapter- 9: Patent Review and New Developments in Cardiac Biomarkers13Free
Chapter- 10: Competitive Landscape3Free
Chapter- 11: Company Profiles40Free
Chapter- 12: Appendix A: Company Addresses and Contact Details7Free
Chapter- 13: Appendix B: Government Regulatory Agencies and Professional Organizations2Free
Chapter- 14: Appendix C: Commonly Used Acronyms Associated with Cardiac Biomarkers5Free

Related Reports

2024 Diagnostics Research Review

Published - Mar 2025 | Publisher - Various Analysts | Code - BIO263A

The Biology industry is a multi-billion-dollar industry whose outlook is supposed to rise in the coming years. This report provides a sampling of the types of quantitative market information, analysis and guidance that has been aiding business decision making since the inception of BCC Research in 1971.

Biomarkers: Technologies and Global Markets

Published - Jan 2025 | Publisher - BCC Publishing | Code - BIO061G

The global market for biomarkers was valued at $63.7 billion in 2023. This market is expected to grow from $70.5 billion in 2024 to $130.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 13.1% from 2024 through 2029.

Point-of-Care Diagnostics: Technologies and Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC043H

The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.

Companion Diagnostics: Technologies and Markets

Published - May 2024 | Publisher - BCC Publishing | Code - BIO077F

The global market for companion diagnostics is estimated to increase from $7.6 billion in 2023 to reach $15.4 billion by 2028, at a compound annual growth rate (CAGR) of 15.2% from 2023 through 2028.

Track the Latest Global Tariff Developments

In today's fast-paced global economy, tariffs are no longer static—they are dynamic levers shaped by geopolitical realignments, supply chain vulnerabilities, inflationary pressures, and sustainability-driven trade reforms. As governments worldwide recalibrate their trade strategies, businesses are left to navigate a maze of shifting rules, rising costs, and regulatory uncertainty.

Our analysis empowers you with real-time updates and in-depth expert analysis on all facets of global tariff activity. From new trade agreements and sanctions to abrupt tariff hikes and retaliatory duties, we monitor developments across borders, sectors, and industries—so you don't have to.

Whether it's the ongoing U.S.–China trade dynamics, the evolving EU Carbon Border Adjustment Mechanism (CBAM), or the emerging policies in India, ASEAN, and Latin America, we provide full-spectrum coverage. We also track multilateral trade negotiations, World Trade Organization (WTO) rulings, and sector-specific duty structures—ensuring you are always ahead of global trade shifts.

With our analysis, you can stay informed, identify risks, and confidently respond to tariff changes—no matter where you operate.

Ready to see what tariff means for your business?

Consult with our experts or request your custom Tariff Impact Brife today

Stay Informed, Stay Competitive

In today's interconnected and unpredictable global economy, staying ahead of tariff shifts is not just important—it's essential. BCC Research provides decision-makers with trusted, research-driven insights that turn uncertainty into opportunity.

Our in-depth market analysis and trade intelligence help you decode how tariff changes impact your specific sector—manufacturing, healthcare, technology, agriculture, or energy. We break down complex data into actionable knowledge through comprehensive reports, expert commentaries, and sector-focused forecasts.

Our analysis includes:

  • Thorough breakdowns of current and proposed tariff policies and how they affect regional and global trade flows.
  • Sector-specific implications, helping you understand the strategic impact on sourcing, pricing, and competitiveness.
  • Forward-looking insights to support risk management, planning, and response strategies for evolving trade conditions.

With BCC Research, you gain more than just information—you gain clarity and confidence to make well-informed decisions in a volatile trade environment.

Don't let tariffs catch you off guard—let our insights guide your strategy.

This is an Excel-only version of the report.

Report Includes

    Total Number of Tables in this Report: 102

  • Summary Table: Global Market Shares of Cardiac Biomarkers, by Region, 2021
  • Summary Table: Global Market for Cardiac Biomarkers, by Type of Biomarker, Through 2027
  • Table 1: Standard Angina Pectoris Classification
  • Table 2: Top 20 Leading Causes of Deaths Globally, 2019
  • Table 3: Estimated Deaths Due to Noncommunicable Diseases, by Gender and Disease, 2019
  • Table 4: Estimated Deaths Due to Cardiovascular Disease, by Gender and Disease, 2019
  • Table 5: Global Health Estimates, by Gender and WHO Region, 2019
  • Table 6: Global Distribution of Male Deaths Caused by Cardiovascular Disease, by Age, 2019
  • Table 7: Global Distribution of Female Deaths Caused by Cardiovascular Disease, by Age Group, 2019
  • Table 8: Estimated Deaths Due to Cardiovascular Disease, by Gender and Disease, 2030
  • Table 9: Estimated Deaths Due to Cardiovascular Disease, by Gender and WHO Region, 2030
Sample Report

Recent Reports

Global Biochip Markets: Microarrays and Lab-on-a-Chip

Published - Jun 2025 | Publisher - BCC Publishing | Code - BIO049G

The global market for biochip was valued at $16.1 billion in 2024 and is estimated to reach $27.8 billion by 2029, at a compound annual growth rate (CAGR) of 11.6% from 2024 through 2029.

Global Cell Line and Membrane Market

Published - Jun 2025 | Publisher - BCC Publishing | Code - BIO178B

The global market for cell lines and membranes was valued at $5.7 billion in 2024 and is estimated to increase from $6.3 billion in 2025 to reach $11.4 billion by 2030, at a compound annual growth rate (CAGR) of 12.5% from 2025 through 2030.

Human Microbiome-based Drugs and Diagnostics: Global Markets

Published - May 2025 | Publisher - BCC Publishing | Code - BIO151B

The global market for human microbiome-based drugs and diagnostics is expected to grow from $393.4 million in 2025 to reach $1.2 billion by the end of 2030, at a compound annual growth rate (CAGR) of 25.6% from 2025 through 2030.

Global Microbiome Sequencing Market

Published - May 2025 | Publisher - BCC Publishing | Code - BIO183B

The global microbiome sequencing market is expected to grow from $1.5 billion in 2024 and is projected to reach $3.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 19.3% during the forecast period of 2024 to 2029.

Proteomics: Technologies and Global Markets

Published - May 2025 | Publisher - BCC Publishing | Code - BIO034G

The global market for proteomic technologies was valued at $27.6 billion in 2024. It is projected to grow from $31.0 billion in 2025 to $57.2 billion by the end of 2030, at a compound annual growth rate (CAGR) of 13.0% from 2025 to 2030.

Top Trending Reports

Global Pharmaceutical Drugs Industry: Competitive Landscape 2023

Published - May 2025 | Publisher - BCC Publishing | Code - PHM263B

This report discusses the global pharmaceutical drugs industry and its competitive landscape in terms of significant player market ranking and top pharmaceutical drugs. Company profiles of the top 50 pharmaceutical companies, innovative products and technologies, trends and market dynamics, competitive intelligence, and regional trends are well-researched and analyzed in this report.

Biologic Therapeutic Drugs: Technologies and Global Markets

Published - May 2025 | Publisher - BCC Publishing | Code - BIO079F

The global market for biologic therapeutic drugs is estimated to increase from $499.2 billion in 2024 to reach $794.5 billion by 2029, at a compound annual growth rate (CAGR) of 9.7% from 2024 through 2029.

Next-Generation Advanced Batteries: Global Markets

Published - May 2025 | Publisher - BCC Publishing | Code - FCB062B

The global market for next-generation advanced batteries is estimated to grow from $1.5 billion in 2024 to reach $5.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 28.5% from 2024 through 2029.

Global Markets and Manufacturing Technologies for Protein Drugs

Published - Apr 2025 | Publisher - BCC Publishing | Code - BIO021G

The global protein drugs market is expected to grow from $441.7 billion in 2024 and is projected to reach $655.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.2% during the forecast period of 2024 to 2029.

Global Markets for Emerging Medical Device Technologies

Published - Mar 2025 | Publisher - BCC Publishing | Code - HLC191C

The global market for emerging medical devices is estimated to increase from $136.6 billion in 2024 to reach $223.9 billion by 2029, at a compound annual growth rate (CAGR) of 10.4% from 2024 through 2029.

Published - Jul-2018| Analyst - Paul Taylor| Code - BIO128C

Report Highlights

The global market for cardiac biomarker will grow from $6.3 billion in 2017 to $9.9 billion by 2022, at a compound annual growth rate (CAGR) of 9.5% for the period of 2017-2022

Report Includes

  • 64 data table and 40 additional tables
  • An overview of the global market for cardiac biomarkers and related technologies
  • Analyses of global market trends, with data from 2016 to 2017, and projections of compound annual growth rates (CAGRs) through 2022
  • Classification of cardiac biomarkers by cerebrovascular, congestive, coronary, hypertensive, and peripheral arterial disease
  • Background and clinical values of cardiac biomarkers, including B-type natriuretic peptide (BNP), N-terminal pro-B-type natriuretic peptide (NT-proBNP), C-reactive protein (CRP), choline, creatine kinase MB (CK-MB), D-dimer, glial fibrillary acidic protein (GFAP), heart fatty acid binding protein (H-FABP), ischemia-modified albumin (IMA), myeloperoxidase (MPO), myoglobin, soluble fragment CD40 ligand (sCD40L), and troponin I (cTnI)/troponin T (cTnT)
  • Examination of the technology regarding diagnostic methods, instrumentation, newly issued patents, and new patent applications
  • Coverage of clinical guidelines and government regulations
  • Comprehensive company profiles of major Players in the Market including Abbott Laboratories, Biomérieux S.A., Bio-Rad Laboratories Inc, Life Diagnostics Inc., Meridian Life Science Inc. Randox Laboratories Ltd., Roche, Sanyo Chemical Industries Ltd., Siemens Ag, and Thermo Fisher Scientific Inc.
Published - Jun-2016| Analyst - Anuj Pathak| Code - BIO128B

Report Highlights

The global cardiac biomarkers market has grown to $4.9 billion in 2015 from $4.4 billion in 2014. The market is expected to grow at a five-year compound annual growth rate (CAGR) of 12.4% from 2015 to 2020, increasing to over $8.8 billion in 2020.

Report Includes

  • An overview of the global market for cardiac biomarkers and related technologies.
  • Analyses of global market trends, with data from 2014, 2015, and projections of CAGRs through 2020.
  • Classification of cardiac biomarkers by cerebrovascular, congestive, coronary, hypertensive, and peripheral arterial disease.
  • Background and clinical values of cardiac biomarkers, including B-type natriuretic peptide (BNP), N-terminal pro-B-type natriuretic peptide (NT-proBNP), C-reactive protein (CRP), choline, creatine kinase MB (CK-MB), D-dimer, glial fibrillary acidic protein (GFAP), heart fatty acid binding protein (H-FABP), ischemia-modified albumin (IMA), myeloperoxidase (MPO), myoglobin, soluble fragment CD40 ligand (sCD40L), and troponin I (cTnI)/troponin T (cTnT).
  • Examination of the technology covering diagnostic methods, instrumentation, newly issued patents, and new patent applications.
  • Clinical guidelines and government regulations.
  • Profiles of major players in the industry.
Published - Mar-2014| Analyst - Cheng-Yuk Lee| Code - BIO128A

Report Highlights

The global market for in vitro diagnostic tests for cardiac biomarkers was estimated at $3.1 billion in 2012 and nearly $4 billion in 2013. This market is predicted to reach $7.2 billion by 2018, at a compound annual growth rate (CAGR) of 12.8% over the five-year period from 2013 to 2018.

Report Includes

  • An overview of the global market for biomarkers for cardiovascular disease (CVD) and related technologies.
  • Analyses of global market trends, with data from 2012, estimates for 2013, and projections of CAGRs for the period 2013 to 2018.
  • Classification of CVD by cerebrovascular, congestive, coronary, hypertensive, and peripheral arterial disease.
  • Background and clinical values of cardiac biomarkers, including B-type natriuretic peptide (BNP), N-terminal pro-B-type natriuretic peptide (NT-proBNP), C-reactive protein (CRP), choline, creatine kinase MB (CK-MB), D-dimer, glial fibrillary acidic protein (GFAP), heart fatty acid binding protein (H-FABP), ischemia-modified albumin (IMA), myeloperoxidase (MPO), myoglobin, soluble fragment CD40 ligand (sCD40L), and troponin I (cTnI)/troponin T (cTnT).
  • Examination of the technology covering diagnostic methods, instrumentation, newly issued patents, and new patent applications.
  • Clinical guidelines and government regulations.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Cardiac Biomarkers: Technologies and Global Markets
Customize Report